Tags

Phase III HARMONi

Akeso cancer trial meets overall survival endpoint against Pembrolizumab

Akeso cancer trial meets overall survival endpoint against Pembrolizumab

September 03, 2026 | 14:50
Biopharmaceutical company Akeso announced its Phase III HARMONi-2 trial met its overall survival endpoint, demonstrating clinical benefits for lung cancer patients compared to Pembrolizumab.

Latest News

Hyosung TNC establishes bio-spandex production system in Vietnam

Hyosung TNC establishes bio-spandex production system in Vietnam

AFRY awarded design contract for LNG project

AFRY awarded design contract for LNG project

Vietnam calls for stronger Russia-ASEAN economic cooperation

Vietnam calls for stronger Russia-ASEAN economic cooperation

Manufacturing production rises at fastest pace in just over two years

Manufacturing production rises at fastest pace in just over two years

Vietnam Investment Review under the Ministry of Finance

Editor-in-Chief: Pham Van Hoanh

Deputy Editors-in-Chief: Le Trong Minh, Ngo Chi Tung, Nguyen Van Hong

Managing Editor: Nguyen Chi Mai

Advertisement  | Contact us

Based on MasterCMS Ultimate Edition 2026 v2.9
Corporate CEO Talk Biz Link PR Newswire Media OutReach Newswire
Investing M&A Outbound Investment Investing in Haiphong
Your Consultant KPMG PwC Indochine Counsel Vilasia Ansarada
Green Growth Energy Efficiency Rethinking Plastics BASF
Property Green Buildings Industrial Properties
Money Insurance Smart Payment Trends Stock Monitor
Infographics
Timeout Travel Hotels & Restaurants The Insider Entertainment Lifestyle
Sports
Photos
Society CSR Swing for the Kids
World News
virs-publications-vir
timeout-vn
ptbv2020